Temozolomide sales reach $1 billion

Sales of Temozolomide*, an anti- Cancer drug developed by Cancer Research UK scientists, have reached $1 billion**. The charity receives a percentage royalty on these sales, which it uses to invest in new research to beat cancer. Read more about this story here...